{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T10:12:33Z","timestamp":1788775953094,"version":"build-2803163510"},"reference-count":36,"publisher":"Oxford University Press (OUP)","issue":"8","license":[{"start":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T00:00:00Z","timestamp":1786320000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000272","name":"National Institute for Health and Care Research","doi-asserted-by":"publisher","award":["NIHR306570"],"award-info":[{"award-number":["NIHR306570"]}],"id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,9,4]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Aims<\/jats:title>\n                    <jats:p>Cancer therapy-related cardiac dysfunction (CTRCD) is a prevalent complication with adverse clinical implications. Guidelines have emphasized the need for reliable baseline risk prediction to guide prevention strategies. While machine learning (ML) has shown promise in cardiovascular medicine, the readiness of ML-based prognostic models for baseline CTRCD risk prediction in cardio-oncology remains unclear.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Aims<\/jats:title>\n                    <jats:p>To systematically review and critically appraise the performance, methodological quality, and clinical applicability of ML-based models for predicting baseline CTRCD risk.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and results<\/jats:title>\n                    <jats:p>A search on Embase and Medline was conducted up to May 2026. Eligible studies used ML algorithms to estimate CTRCD risk prior to cancer treatment. Data were extracted using an adapted version of the CHARMS checklist. Risk of bias (ROB) and reporting quality were assessed using PROBAST and TRIPOD + AI. Nine studies were included. Seven studies included novel models using multiple clinical and imaging predictors, while two repurposed or validated existing AI-enhanced electrocardiography (ECG) models. The levels of discrimination were at least moderate (AUC 0.65\u20130.88), calibration was only reported in two studies, and external validation in one. Multiparametric models showed higher performance metrics than ECG-only models but were methodologically constrained. Overall, most studies were limited by variability in outcome definitions, low event rates, limited transparency in reporting, and a lack of reproducibility measures.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Current ML-based models for predicting CTRCD remain underdeveloped for clinical use. The present findings highlight the need for further work to optimize models by incorporating rigorous study designs, with emphasis on methodological clarity, standardized outcome definitions, and external validation to improve reproducibility.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/ehjdh\/ztag127","type":"journal-article","created":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T11:09:36Z","timestamp":1786100976000},"source":"Crossref","is-referenced-by-count":0,"title":["Machine learning\u2014enhanced baseline risk prediction models for cancer therapy related cardiac dysfunction: a systematic review and critical appraisal of methodological quality"],"prefix":"10.1093","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9554-2026","authenticated-orcid":false,"given":"Maria Sol","family":"Andres","sequence":"first","affiliation":[{"name":"Cardio-Oncology Service, Royal Brompton Hospital Centre of Excellence, Guy\u2019s and St Thomas\u2019 NHS Foundation Trust , Sydney Street, London SW3 6NP ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vijay","family":"Maharahan","sequence":"additional","affiliation":[{"name":"Cardio-Oncology Service, Royal Brompton Hospital Centre of Excellence, Guy\u2019s and St Thomas\u2019 NHS Foundation Trust , Sydney Street, London SW3 6NP ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Pons Rivarola","sequence":"additional","affiliation":[{"name":"Cardio-Oncology Service, Royal Brompton Hospital Centre of Excellence, Guy\u2019s and St Thomas\u2019 NHS Foundation Trust , Sydney Street, London SW3 6NP ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis","family":"Garcia Rodriguez","sequence":"additional","affiliation":[{"name":"Cardio-Oncology Service, Royal Brompton Hospital Centre of Excellence, Guy\u2019s and St Thomas\u2019 NHS Foundation Trust , Sydney Street, London SW3 6NP ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franck","family":"Thuny","sequence":"additional","affiliation":[{"name":"Cardio-Oncology Service, Royal Brompton Hospital Centre of Excellence, Guy\u2019s and St Thomas\u2019 NHS Foundation Trust , Sydney Street, London SW3 6NP ,","place":["UK"]},{"name":"Aix-Marseille University, University Mediterranean Center of Cardio-Oncology, Unit of Heart Failure and Valvular Heart Diseases, Department of Cardiology, North Hospital , Assistance Publique, Marseille ,","place":["France"]},{"name":"Centre for CardioVascular and Nutrition Research (C2VN), Inserm 1263, Inrae 1260 , Marseille ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sivatharshini","family":"Ramalingam","sequence":"additional","affiliation":[{"name":"Cardio-Oncology Service, Royal Brompton Hospital Centre of Excellence, Guy\u2019s and St Thomas\u2019 NHS Foundation Trust , Sydney Street, London SW3 6NP ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matilda","family":"Howe","sequence":"additional","affiliation":[{"name":"Cardio-Oncology Service, Royal Brompton Hospital Centre of Excellence, Guy\u2019s and St Thomas\u2019 NHS Foundation Trust , Sydney Street, London SW3 6NP ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mamas A","family":"Mamas","sequence":"additional","affiliation":[{"name":"Keele Cardiovascular Research Group, Keele University , Keele ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amitava","family":"Banerjee","sequence":"additional","affiliation":[{"name":"Institute of Health Informatics, University College London , London ,","place":["UK"]},{"name":"Barts Heart Centre, Barts Health NHS Trust , London ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0245-7090","authenticated-orcid":false,"given":"Charlotte","family":"Manisty","sequence":"additional","affiliation":[{"name":"Barts Heart Centre, Barts Health NHS Trust , London ,","place":["UK"]},{"name":"Institute of Cardiovascular Science, University College London , London ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arjun K","family":"Ghosh","sequence":"additional","affiliation":[{"name":"Barts Heart Centre, Barts Health NHS Trust , London ,","place":["UK"]},{"name":"Hatter Cardiovascular Institute, University College London Hospital , London ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aditya S","family":"Bharadwaj","sequence":"additional","affiliation":[{"name":"Miller School of Medicine, University of Miami , Miami ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander R","family":"Lyon","sequence":"additional","affiliation":[{"name":"Cardio-Oncology Service, Royal Brompton Hospital Centre of Excellence, Guy\u2019s and St Thomas\u2019 NHS Foundation Trust , Sydney Street, London SW3 6NP ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed O","family":"Mohamed","sequence":"additional","affiliation":[{"name":"Institute of Health Informatics, University College London , London ,","place":["UK"]},{"name":"Barts Heart Centre, Barts Health NHS Trust , London ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,8,10]]},"reference":[{"key":"2026090705570632300_ztag127-B1","author":"World Heart Organisation"},{"key":"2026090705570632300_ztag127-B2","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1093\/eurheartj\/ehab674","article-title":"Defining cardiovascular toxicities of cancer therapies: an International Cardio-Oncology Society (IC-OS) consensus statement","volume":"43","author":"Herrmann","year":"2022","journal-title":"Eur Heart J"},{"key":"2026090705570632300_ztag127-B3","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1161\/CIRCULATIONAHA.114.013777","article-title":"Early detection of anthracycline cardiotoxicity and improvement with heart failure therapy","volume":"131","author":"Cardinale","year":"2015","journal-title":"Circulation"},{"key":"2026090705570632300_ztag127-B4","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s10549-021-06192-w","article-title":"Incidence of cardiotoxicity and validation of the Heart Failure Association-International Cardio-Oncology Society risk stratification tool in patients treated with trastuzumab for HER2-positive early breast cancer","volume":"188","author":"Battisti","year":"2021","journal-title":"Breast Cancer Res Treat"},{"key":"2026090705570632300_ztag127-B5","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.jaccao.2024.02.001","article-title":"Cardiovascular concerns, cancer treatment, and biological and chronological aging in cancer: JACC family series","volume":"6","author":"Ioffe","year":"2024","journal-title":"JACC CardioOncol"},{"key":"2026090705570632300_ztag127-B6","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1002\/ejhf.1920","article-title":"Baseline cardiovascular risk assessment in cancer patients scheduled to receive cardiotoxic cancer therapies: a position statement and new risk assessment tools from the Cardio-Oncology Study Group of the Heart Failure Association of the European Society of Cardiology in collaboration with the International Cardio-Oncology Society","volume":"22","author":"Lyon","year":"2020","journal-title":"Eur J Heart Fail"},{"key":"2026090705570632300_ztag127-B7","doi-asserted-by":"crossref","first-page":"4229","DOI":"10.1093\/eurheartj\/ehac244","article-title":"2022 ESC guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS)","volume":"43","author":"Lyon","year":"2022","journal-title":"Eur Heart J"},{"key":"2026090705570632300_ztag127-B8","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.0569","article-title":"Risk prediction models for cardiotoxicity of chemotherapy among patients with breast cancer: a systematic review","volume":"6","author":"Kabore","year":"2023","journal-title":"JAMA Netw Open"},{"key":"2026090705570632300_ztag127-B9","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2025-084062","article-title":"Risk prediction models for cancer therapy related cardiac dysfunction in patients with cancer and cancer survivors: systematic review and meta-analysis","volume":"390","author":"Gomes","year":"2025","journal-title":"BMJ"},{"key":"2026090705570632300_ztag127-B10","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.jaccao.2024.05.015","article-title":"Predictive performance of cardiovascular risk scores in cancer survivors from the UK biobank","volume":"6","author":"McCracken","year":"2024","journal-title":"JACC CardioOncol"},{"key":"2026090705570632300_ztag127-B11","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1126\/science.adg8538","article-title":"Illusory generalizability of clinical prediction models","volume":"383","author":"Chekroud","year":"2024","journal-title":"Science"},{"key":"2026090705570632300_ztag127-B12","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2024-079183","article-title":"Extension of the PRISMA 2020 statement for living systematic reviews (PRISMA-LSR): checklist and explanation","volume":"387","author":"Akl","year":"2024","journal-title":"BMJ"},{"key":"2026090705570632300_ztag127-B13","author":"Andres MSM"},{"key":"2026090705570632300_ztag127-B14","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/s12874-023-01849-0","article-title":"CHARMS and PROBAST at your fingertips: a template for data extraction and risk of bias assessment in systematic reviews of predictive models","volume":"23","author":"Fernandez-Felix","year":"2023","journal-title":"BMC Med Res Methodol"},{"key":"2026090705570632300_ztag127-B15","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2023-078378","article-title":"TRIPOD + AI statement: updated guidance for reporting clinical prediction models that use regression or machine learning methods","volume":"385","author":"Collins","year":"2024","journal-title":"BMJ"},{"key":"2026090705570632300_ztag127-B16","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCOUTCOMES.124.011504","article-title":"Artificial intelligence-enhanced risk stratification of cancer therapeutics-related cardiac dysfunction using electrocardiographic images","volume":"18","author":"Oikonomou","year":"2025","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"2026090705570632300_ztag127-B17","doi-asserted-by":"crossref","first-page":"2536","DOI":"10.1038\/s41467-024-45733-x","article-title":"Artificial intelligence-enabled prediction of chemotherapy-induced cardiotoxicity from baseline electrocardiograms","volume":"15","author":"Yagi","year":"2024","journal-title":"Nat Commun"},{"key":"2026090705570632300_ztag127-B18","first-page":"1","article-title":"Risk stratification for cardiotoxicity in breast cancer patients: predicting early decline of LVEF after treatment()","volume":"2023","author":"Tsiouris","year":"2023","journal-title":"Annu Int Conf IEEE Eng Med Biol Soc"},{"key":"2026090705570632300_ztag127-B19","doi-asserted-by":"crossref","first-page":"2731","DOI":"10.1007\/s00204-022-03341-y","article-title":"An artificial intelligence approach for predicting cardiotoxicity in breast cancer patients receiving anthracycline","volume":"96","author":"Chang","year":"2022","journal-title":"Arch Toxicol"},{"key":"2026090705570632300_ztag127-B20","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1007\/s12012-021-09708-4","article-title":"Using machine learning approaches to predict short-term risk of cardiotoxicity among patients with colorectal cancer after starting fluoropyrimidine-based chemotherapy","volume":"22","author":"Li","year":"2022","journal-title":"Cardiovasc Toxicol"},{"key":"2026090705570632300_ztag127-B21","doi-asserted-by":"crossref","first-page":"7046","DOI":"10.1109\/JBHI.2025.3552819","article-title":"TPNET: a time-sensitive small sample multimodal network for cardiotoxicity risk prediction","volume":"29","author":"He","year":"2025","journal-title":"IEEE J Biomed Health Inform"},{"key":"2026090705570632300_ztag127-B22","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1007\/s11517-025-03289-y","article-title":"Predicting doxorubicin-induced cardiotoxicity in breast cancer: leveraging machine learning with synthetic data","volume":"63","author":"Araujo","year":"2025","journal-title":"Med Biol Eng Comput"},{"key":"2026090705570632300_ztag127-B23","doi-asserted-by":"crossref","first-page":"1707889","DOI":"10.3389\/fcvm.2025.1707889","article-title":"Machine learning models using multimodal data accurately predict chemotherapy-induced cardiotoxicity in breast cancer","volume":"12","author":"Chen","year":"2026","journal-title":"Front Cardiovasc Med"},{"key":"2026090705570632300_ztag127-B24","doi-asserted-by":"crossref","first-page":"117","DOI":"10.3390\/cancers18010117","article-title":"A TabNet-based multidimensional deep learning model for predicting doxorubicin-induced cardiotoxicity in breast cancer patients","volume":"18","author":"Cao","year":"2026","journal-title":"Cancers (Basel)"},{"key":"2026090705570632300_ztag127-B25","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1093\/eurheartj\/ehae496","article-title":"Anthracycline-induced cardiovascular toxicity: validation of the Heart Failure Association and International Cardio-Oncology Society risk score","volume":"46","author":"Rivero-Santana","year":"2025","journal-title":"Eur Heart J"},{"key":"2026090705570632300_ztag127-B26","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1056\/NEJMoa052306","article-title":"Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer","volume":"353","author":"Piccart-Gebhart","year":"2005","journal-title":"N Engl J Med"},{"key":"2026090705570632300_ztag127-B27","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.annonc.2019.10.023","article-title":"Management of cardiac disease in cancer patients throughout oncological treatment: ESMO consensus recommendations","volume":"31","author":"Curigliano","year":"2020","journal-title":"Ann Oncol"},{"key":"2026090705570632300_ztag127-B28","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1016\/j.jcmg.2018.06.005","article-title":"Cardiotoxicity and cardiac monitoring among chemotherapy-treated breast cancer patients","volume":"11","author":"Henry","year":"2018","journal-title":"JACC Cardiovasc Imaging"},{"key":"2026090705570632300_ztag127-B29","doi-asserted-by":"crossref","first-page":"2980","DOI":"10.1200\/JCO.2018.77.9736","article-title":"Risk-imaging mismatch in cardiac imaging practices for women receiving systemic therapy for early-stage breast cancer: a population-based cohort study","volume":"36","author":"Thavendiranathan","year":"2018","journal-title":"J Clin Oncol"},{"key":"2026090705570632300_ztag127-B30","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1007\/s10549-021-06135-5","article-title":"Cardiac assessment in Australian patients receiving (neo)adjuvant trastuzumab for HER2-positive early breast cancer: a population-based study","volume":"187","author":"Tang","year":"2021","journal-title":"Breast Cancer Res Treat"},{"key":"2026090705570632300_ztag127-B31","first-page":"42","article-title":"Cardiovascular events in CML patients treated with nilotinib: validation of the HFA-ICOS baseline risk score","volume":"10","author":"Fernando","year":"2024","journal-title":"Cardiooncology"},{"key":"2026090705570632300_ztag127-B32","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1002\/ehf2.13897","article-title":"The new HFA\/ICOS risk assessment tool to identify patients with chronic myeloid leukaemia at high risk of cardiotoxicity","volume":"9","author":"Di Lisi","year":"2022","journal-title":"ESC Heart Fail"},{"key":"2026090705570632300_ztag127-B33","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.jclinepi.2004.06.017","article-title":"Substantial effective sample sizes were required for external validation studies of predictive logistic regression models","volume":"58","author":"Vergouwe","year":"2005","journal-title":"J Clin Epidemiol"},{"key":"2026090705570632300_ztag127-B34","first-page":"54","article-title":"Cancer therapy-related cardiac dysfunction after radiation therapy for breast cancer: results from the BACCARAT cohort study","volume":"10","author":"Honaryar","year":"2024","journal-title":"Cardiooncology"},{"key":"2026090705570632300_ztag127-B35","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJMoa1209825","article-title":"Risk of ischemic heart disease in women after radiotherapy for breast cancer","volume":"368","author":"Darby","year":"2013","journal-title":"N Engl J Med"},{"key":"2026090705570632300_ztag127-B36","doi-asserted-by":"crossref","first-page":"455","DOI":"10.3390\/medicina56090455","article-title":"Comparison of conventional statistical methods with machine learning in medicine: diagnosis, drug development, and treatment","volume":"56","author":"Rajula","year":"2020","journal-title":"Medicina (Kaunas)"}],"container-title":["European Heart Journal - Digital Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ehjdh\/advance-article-pdf\/doi\/10.1093\/ehjdh\/ztag127\/70603322\/ztag127.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ehjdh\/article-pdf\/7\/8\/ztag127\/70603322\/ztag127.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ehjdh\/article-pdf\/7\/8\/ztag127\/70603322\/ztag127.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T09:57:19Z","timestamp":1788775039000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ehjdh\/article\/doi\/10.1093\/ehjdh\/ztag127\/8758361"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,10]]},"references-count":36,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,9,4]]}},"URL":"https:\/\/doi.org\/10.1093\/ehjdh\/ztag127","relation":{},"ISSN":["2634-3916"],"issn-type":[{"value":"2634-3916","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,10]]},"published":{"date-parts":[[2026,8,10]]},"article-number":"ztag127"}}